Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1441-1450 of 1,460) with videos related to

Pageof 146
Sort By:
Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primatesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Science (New York, N.Y.)|July 2, 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Cell Reports|May 14, 2022
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Nature Medicine|May 10, 2016
Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationAndrew S Ishizuka, Kirsten E Lyke, Adam DeZure, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.
Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman PrimatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Pageof 146

Showing results (1441-1450 of 1,460) with videos related to

Sort By:
Pageof 146
Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primatesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Science (New York, N.Y.)|July 2, 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Cell Reports|May 14, 2022
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Nature Medicine|May 10, 2016
Protection against malaria at 1 year and immune correlates following PfSPZ vaccinationAndrew S Ishizuka, Kirsten E Lyke, Adam DeZure, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S Corbett, Darin Edwards, Sarah R Leist, et al.
Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Nature|August 7, 2020
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S Corbett, Darin K Edwards, Sarah R Leist, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsKathryn Westendorf, Stefanie Žentelis, Lingshu Wang, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman PrimatesKizzmekia S Corbett, Martha C Nason, Britta Flach, et al.
Pageof 146